Dynavax Technologies
DVAX
#4936
Rank
A$2.60 B
Marketcap
A$22.23
Share price
0.19%
Change (1 day)
6.87%
Change (1 year)

Market capitalization of Dynavax Technologies (DVAX)

Market cap: A$2.60 Billion

As of February 2026 Dynavax Technologies has a market cap of A$2.60 Billion. This makes Dynavax Technologies the world's 4936th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dynavax Technologies from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026A$2.60 B-3.21%
2025A$2.69 B-1.86%
2024A$2.74 B3.58%
2023A$2.65 B32.96%
2022A$1.99 B-14.31%
2021A$2.32 B265.06%
2020A$0.63 B-6.93%
2019A$0.68 B-16.08%
2018A$0.81 B-43.75%
2017A$1.45 B587.48%
2016A$0.21 B-83.44%
2015A$1.27 B135.27%
2014A$0.54 B-6.15%
2013A$0.57 B15.19%
2012A$0.50 B22.09%
2011A$0.41 B12.74%
2010A$0.36 B324.48%
2009A$85.8 M80.82%
2008A$47.45 M-79.58%
2007A$0.23 B-49.75%
2006A$0.46 B239.54%
2005A$0.13 B-44.34%
2004A$0.24 B

End of Day market cap according to different sources

On Feb 4th, 2026 the market cap of Dynavax Technologies was reported to be:

A$2.60 Billion
by Nasdaq info icon info icon
A$2.60 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$218.19 B 8,260.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$282.84 B 10,737.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$38.98 B 1,393.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$260.00 B 9,862.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$423.54 B 16,128.46%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$832.86 B 31,812.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$165.44 B 6,239.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
A$0.14 B-94.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$58.47 B 2,140.37%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel